Summary
Part I of this article, which appeared in the previous issue of the Journal, covered the effects or lack of effects on theophylline clearance of sympathomimetics, corticosteroids, antihistamines and other antiallergy drugs, antimicrobial agents, Phenytoin, carbamazepine, barbiturates, antacids and activated charcoal. In Part II, this discussion is extended to the effects of other agents. Overall summaries, both textual and tabular, appear in Part I.
Similar content being viewed by others
References
Aberncthy DR, Egan JM, Carrum G. Calcium antagonists inhibit oxidative drug biotransformation. Clinical Research 34: 394A, 1986
Abernethy DR, Egan JM, Dickinson TH, Carrum G. Substrate-selective inhibition by verapamil and diltiazem: differential disposition of antipyrine and theophylline in humans. Journal of Pharmacologv and Experimental Therapeutics 244: 994–999, 1988
Adebayo GI. Interaction between Phenytoin and theophylline in healthy volunteers. Clinical and Experimental Pharmacology and Physiology 15: 883–887, 1988
Adebayo GI, Coker HAB. Cimetidine inhibition of theophylline elimination: the influence of adult age and time course. Biopharmaceutics and Drug Disposition 8: 149–158, 1987
Adebayo GI, Mabadeje AFB. Effect of nifedipine on antipyrine and theophylline disposition. Biopharmaceutics and Drug Disposition II: 157–164, 1990
Albin H, Vincon G, Bezier M, Pehourco F, Cabanieu G. Pharmacocinétique de la theophylline par voie orale chez des malades asthmatiques sous corticothérapie au long cours. Thérapie 38: 333–339, 1983
Al-Turk WA, Shaheen OM, Othman S, Khalaf RM, Awidi AS. Effect of ofloxacin on the pharmacokinetics of a single intravenous theophylline dose. Therapeutic Drug Monitoring 10: 160–163, 1988
Ambrose PJ, Harralson AF. Lact of effect of Cimetidine on theophylline clearance. Drug Intelligence and Clinical Pharmacy 15: 389–390, 1981a
Ambrose PJ, Harralson AF. Lack of effect of Cimetidine on theophylline clearance — reply. Drug Intelligence and Clinical Pharmacy 15: 810, 1981b
Amirav I, Amitai Y, Avital A, Godfrey S. Enchancement of theo-phvlline clearance bv intravenous albuterol. Chest 94: 444–445, 1988
Anderson JL, Ayers JW, Hall CA. Potential pharmacokinetic interaction between theophylline and prednisone. Clinical Pharmacy 3: 187–189, 1984
Anderson JR, Poklis A, Slavm RG. A fatal case of theophylline intoxication. Archives of Internal Medicine 143: 559–560, 1983
Anolik R, Kolski GB, Schaible DH, Ratner J. Transient alteration of theophylline half-life: possible association with herpes simplex infection. Annals of Allergy 49: 109–111, 1982
Arnold LA, Spurbeck GH, Shelver WH, Henderson WM. Effect of an antacid on gastrointestinal absorption of theophylline. American Journal of Hospital Pharmacy 36: 1059–1062, 1979
Bachmann K, Schwanz J, Forney Jr RB, Jauregui L. Impact of cefaclor on the pharmacokinetics of theophylline. Therapeutic Drug Monitoring 8: 151–154, 1986
Bachmann KA, Schwartz JI, Jauregui L. Predicting the ciprofloxacin-theophylline interaction from single plasma theophylline measurements. British Journal of Clinical Pharmacology 26: 191–194, 1988
Bachmann K, Schwartz J, Jauregui L, Martin M, Nunlee M. Failure of Ceftibuten to alter single dose theophylline clearance. Journal of Clinical Pharmacology 30: 444–448, 1990
Bauman JH, Kimelblatt BJ. Comment on effect of Cimetidine on theophylline clearance. Drug Intelligence and Clinical Pharmacy 15: 808, 1981
Bauman JH, Kimelblatt BJ, Caraccio TR, Silverman HM, Simon GI. et al. Cimetidine-theophylline interaction: report of four patients. Annals of Allergy 48: 100–102, 1982
Beckmann J, Elsasser W, Gundert-Remy U, Hertrampf R. Enoxacin — a potent inhibitor of theophylline metabolism. European Journal of Clinical Pharmacology 33: 227–230, 1987
Bern JL, Mann RD. Danger of interaction between ciprofloxacin and theophylline. British Medical Journal 296: 1131, 1988
Berlinger WG, Spector R, Goldberg MJ, Johnson GF, Quee CK, et al. Enhancement of theophylline clearance by oral activated charcoal. Clinical Pharmacology and Therapeutics 33: 351–354, 1983
Birkett DJ, Miners JO, Attwood J. Evidence for a dual action of sulphinpyrazone on drug metabolism in man: theophylline-sulphinpvrazone interaction. British Journal of Clinical Pharmacology 15: 567–569, 1983
Birkett DJ, Miners JO, Gallus A, Attwood J, Wanwimolruk S. Sulphinpyrazone can inhibit or induce drug metabolism: effects on tolbutamide and theophylline metabolism in man. British Journal of Clinical Pharmacology 14: 574P–575P, 1982
Bowles SK, Popovski Z, Rybak MJ, Beckman HB, Edwards DJ. Effect of norfloxacin on theophylline pharmacokinetics at steady state. Antimicrobial Agents and Chemotherapy 32: 510–512, 1988
Boyce EG, Dukes GE, Rollins DE, Sudds TW. The effect of rifampin on theophylline kinetics. Clinical Pharmacology and Therapeutics 37: 183, 1985
Boyce EG, Dukes GE, Rollins DE, Sudds TW. The effect of rifampin on theophylline kinetics. Journal of Clinical Pharmacology 26: 696–699, 1986
Branigan TA, Robbins RA, Cady WJ, Nickols JG, Ueda CT. The effects of erythromycin on the absorption and disposition kinetics of theophylline. European Journal of Clinical Pharmacology 21: 115–120, 1981
Bratel T, Billing B, Dahlqvist R. Felodipine reduces the absorption of theophylline in man. European Journal of Clinical Pharmacology 36: 481–485, 1989
Brazier JL, Kofman J, Faucon G, Perrin-Fayolle M, Lepape A, et al. Retard d’élimination de la theophylline du à la troléan-domvcine: absence d’effet de la josamycine. Thérapie 35: 545–549, 1980
Breen KJ, Bury R, Desmond PV, Mashford ML, Morphea B, et al. Effects of Cimetidine and ranitidine on hepatic drug metabolism. Clinical Pharmacology and Therapeutics 31: 297–300, 1982
Brion N, Naline E, Beaumont D, Pays M, Advenier C. Lack of effect of terfenadine on theophylline pharmacokinetics and metabolism in normal subjects. British Journal of Clinical Pharmacology 27: 391–395, 1989
Britton L, Ruben FL. Serum theophylline levels after influenza vaccination. Canadian Medical Association Journal 126: 1375, 1982
Buchanan N, Hurwitz S, Butler P. Asthma — a possible interaction between hydrocortisone and theophylline. South African Medical Journal 56: 1147–1148, 1979
Bukowskyj M, Munt PW, Wigle R, Nakatsu K. Theophylline clearance: lack of effect of influenza vaccination and ascorbic acid American Review of Respiratory Disease 129: 672–675, 1984
Bunker-Soler AL, Leavengood DC, Nelson HS. The effect of corticosteroids on theophylline metabolism. Annals of Allergy 47: 133, 1981
Burnakis TG, Seidon M, Czaplicki A. Increased serum theophylline concentrations secondary to oral verapamil. Clinical Pharmacy 2: 458–461, 1983
Caldwell J, Lancaster R, Monks TJ, Smith RL. The influence of dietary methylxanthines on the metabolism and pharmacokinetics of intravenously administered theophylline. British Journal of Clinical Pharmacology 4: 637P–638P, 1977
Caldwell J, Monks TJ, Lawrie S, Smith RL. Dietary methylxanthines as determinants of theophylline metabolism in man. Pharmacologist 21: 173, 1979
Campbell MA, Plachetka JR. Jackson JE, Moon JF, Finley PR. Cimetidine decreases theophylline clearance. Annals of Internal Medicine 95: 68–69, 1981
Carpentiere G, Castello F, Marino S. Effects of adding verapamil to treatment with theophylline in chronic asthma. Chest 88: 32S, 1985
Cerasa LA, Bertino Jr JS, Ludwig EA, Savliwala M, Middleton Jr E, et al. Lack of effect of atenolol on the pharmacokinetics of theophylline. British Journal of Clinical Pharmacology 26: 800–802, 1988
Chang K.C, Bell TD, Lauer BA, Chai H. Altered theophylline pharmacokinetics during acute respiratory viral illness. Lancet I: 1132, 1978
Chang TMS, Espinosa-Melendez E, Francoeur TE, Eade NR. Albumin-collodion activated charcoal hemoperfusion in the treatment of severe theophylline intoxication in a 3-year-old patient. Pediatrics 65: 811–814, 1980
Charles BG, Schnieder JJ, Norris RLG, Ravenscroft PJ. Teme-lastine does not affect theophylline pharmacokinetics in normal subjects. British Journal of Clinical Pharmacology 24: 673–675, 1987
Christopher MA, Harman E, Hendeles L. Clinical relevance of the interaction of theophylline with diltiazem or nifedipine. Chest 95: 309–313, 1989
Clark CJ, Boyd G. Theophylline pharmacokinetics during respiratory viral infection. Lancet I: 492, 1979
Cluxton JR, Rivera JO, Ritschel WA, Pesce AJ, Hanenson IB. Cimetidine-theophylline interaction. Annals of Internal Medicine 96: 684, 1982
Cohen IA, Johnson CE, Berardi RR, Hyneck ML, Achem-Karem SR. Effects of age and Cimetidine dose on the magnitude of the cimetidine-theophylline drug interaction. Gastroenterology 86: 1050, 1984
Cohen IA, Johnson CE, Berardi RR, Hyneck ML, Achem SR. Cimetidine-theophylline interaction: effects of age and Cimetidine dose. Therapeutic Drug Monitoring 7: 426–434, 1985
Colli A, Buccino G, Cocciolo M, Parravicini R, Elli GM, et al. Ticlopidine-theophylline interaction. Clinical Pharmacology and Therapeutics 41: 358–362, 1987
Conlon PF, Grambau GR, Johnson CE, Weg JG. Effect of intravenous furosemide on serum theophylline concentration. American Journal of Hospital Pharmacy 38: 1345–1347, 1981
Conrad KA, Nyman DW. Effects of metoprolol and propranolol on theophylline elimination. Clinical Pharmacology and Therapeutics 28: 463–467, 1980
Conrad KA, Woodworth JR. Orciprenaline does not alter theophylline elimination. British Journal of Clinical Pharmacology 12: 756–757, 1981
Corsi CM, Nafziger AN, Pieper JA, Bertino Jr JS. Lack of effect of atenolol and nadolol on the metabolism of theophylline. British Journal of Clinical Pharmacology 29: 265–268, 1990
Couet W, Ingrand I, Reigner B, Girault J, Bizouard J, et al. Lack of effect of ponsinomycin on the plasma pharmacokinetics of theophylline. European Journal of Clinical Pharmacology 37: 101–104, 1989
Cremer KF, Secor J, Speeg KV. The effect of route of administration on the cimetidine-theophylline drug interaction. Journal of Clinical Pharmacology 29:451–456, 1989
Crowley JJ, Cusack BJ, Jue SG. Koup JR, Park BK. et al. Aging and drug interactions: II. Effect of Phenytoin and smoking on the oxidation of theophylline and Cortisol in healthy men. Journal of Pharmacology and Experimental Therapeutics 245: 513–523, 1988
Crowley JJ, Cusack BJ, Jue SG, Koup JR, Vestal RE. Cigarette smoking and theophylline metabolism: effects of Phenytoin. Clinical Pharmacology and Therapeutics 42: 334–340, 1987
Cummins LH, Kozak PP, Gillman SA. Theophylline determinations. Annals of Allergy 37: 450–451, 1976
Cummins LH, Kozak PP, Gillman SA. Erythromycin’s effect on theophylline blood level. Pediatrics 59: 144–145, 1977
Cusack BJ, Dawson GW, Mercer G, Vestal RE. Theophylline metabolism but not the inhibitory effect of Cimetidine is impaired in the elderly. Clinical Research 32: 240A, 1984
Cusack BJ, Dawson GW, Mercer GD, Vestal RE. Cigarette smoking and theophylline metabolism: effects of Cimetidine. Clinical Pharmacology and Therapeutics 37: 330–336, 1985
Dal Negro R, Pomari C, Zoccatelli O, Trevisan F, Carloni C. et al. Pharmacokinetics of theophylline and the H2-antagonist drugs Cimetidine and ranitidine. International Journal of Clinical Pharmacology. Therapy and Toxicology 22: 221–226, 1984
Dal Negro R, Turco P, Zoccatelli O, Trevisan F, Pomart C: Hi-antagonist derangement of the kinetics of sustained-release oral theophylline. International Journal of Clinical Pharmacology. Therapy and Toxicology 23: 329–332, 1985
Danziger Y, Garty M, Volwitz B, Ilfeld D, Varsano I, et al. Reduction of serum theophylline levels by terbutaline in children with asthma. Clinical Pharmacology and Therapeutics 37: 469–471, 1985
Darzentas U, Stewart RB, Curry SH, Yost RL. Effect of antacid on bioavailability of a sustained-release theophylline tablet preparation. Drug Intelligence and Clinical Pharmacy 17: 555–557, 1983
Dawson KP, Fergusson DM. Effects of oral theophylline and oral salbutamol in the treatment of asthma. Archives of Disease in Childhood 57: 674–676, 1982
DeAngelis C, Walker SE, Bartle WR. Effect of low dose Cimetidine on theophylline metabolism. Clinical Pharmacology and Therapeutics 33: 262, 1983a
DeAngelis C, Walker SE, Bartle WR. Effect of low-dose Cimetidine on theophylline metabolism. Clinical Pharmacy 2: 563–567, 1983b
Debruyne D, Jehan A, Bigot M-C, Lechevalier B, Prevost J-N, et al. Spiramycin has no effect on serum theophylline in asthmatic patients. European Journal of Clinical Pharmacology 30: 505–507, 1986
de Lauture D, Rey E, D’Athis P, Richard M-O, Paccaly D, et al. Pharmacokinetic interactions between theophylline and rio-prostil. Scandinavian Journal of Gastroenterology 24 (Suppl. 164) 63–67, 1989
Dobbs JH, Smith RN. Ranitidine and theophylline. Annals of Internal Medicine 100: 769, 1984
Fenje PC, Isles AF, Ballodano A, Macleod SM, Soldin S. Interaction of Cimetidine and theophylline in two infants. Canadian Medical Association Journal 126: 1178, 1982
Fergusson R, Scott CM, Rafferty P, Gaddie J. Effect of prednisolone on theophylline pharmacokinetics in patients with chronic airflow obstruction. Thorax 42: 195–198, 1987
Fernandes E, Melewicz FM. Ranitidine and theophylline. Annals of Internal Medicine 100: 459, 1984
Fischer RG, Booth BH, Mitchell DQ, Kibbe AH. Influence of trivalent influenza vaccine on serum theophylline levels. Canadian Medical Association Journal 126: 1312–1313, 1982
Fitzsimmons WE, Luskin SS, Macleod CM, Luskin AT. Single-dose study of the effect of terfenadine on theophylline absorption and disposition. Annals of Allergy 62: 213–214, 1989
Fleetham JA, Nakatsu K, Munt PW. Theophylline pharmacokinetics and respiratory infections. Lancet 2: 898, 1978
Fourtillan JB, Granier J, Saint-Salvi B, Salmon J, Surjus A. et al. Pharmacokinetics of ofloxacin and theophylline alone and in combination. Infection 14 (Suppl.1): S67–S69, 1986
Fraschini F, Scaglione F, Maierna G, Cogo R, Furcolo F, et al. Ribavirin influence on theophylline plasma levels in adults and children. International Journal of Clinical Pharmacology. Therapy and Toxicology 26: 30–32, 1988
Gardner ME, Sikorski GW. Ranitidine and theophylline. Annals of Internal Medicine 102: 559, 1985
Gardner MJ, Tornalore K.M, Jusko WJ, Kanarkowski R. Effects of tobacco smoking and oral contraceptive use on theophylline disposition. British Journal of Clinical Pharmacology 16: 271–280, 1983
Garty M, Cohen E, Mazar A, Llfeld DN, Spitzer S, et al. Effect of nifedipine and theophylline in asthma. Clinical Pharmacology and Therapeutics 40: 195–198, 1986
Garty M, Paul-Keslin L, Ilfeld DN, Mazar A, Spitzer S, et al. Increased theophylline clearance in asthmatic patients due to tcrbulaline. European Journal of Clinical Pharmacology 36: 25–28, 1989
Gibson GA, Blouin RA, Bauer LA, Rapp RP, Tibbs P.A. Influence of high-dose pentobarbital on theophylline pharmacokinetics: a case report. Therapeutic Drug Monitoring 7: 181–184, 1985
Gin AS, Stringer KA, Welage LS, Wilton JH, Matthews GE. The effect of verapamil on the pharmacokinetic disposition of theophylline in cigarette smokers. Journal of Clinical Pharmacology 29: 728–732, 1989
Godard, Selles JPh, Bres J, Terrai C, Brun S, et al. Influence d’un bctamimétique sur les paramètres pharmacocinétiques de la theophylline Revue Française d’Allergologie et d’Immunologie Clinique 21: 180, 1981
Goldstein EO, Eney RD, Mellits ED, Solomon H, Johnson G. The effect of phenobarbital on theophylline metabolism in asthmatic children. Annals of Allergy 39: 69, 1977
Goldstein RS, Cheung OT, Seguin R, Lobley G, Johnson AC. Decreased elimination of theophylline after influenza vaccination. Canadian Medical Association Journal 126: 470, 1982
Gomolin IH, Chapron DJ, Luhan PA. Lack of effect of influenza vaccine on theophylline levels and warfarin anticoagulation in the elderlv. Journal of the American Geriatrics Society 33: 269–272, 1985
Götz VP, Dolly FR, Block AJ. Influence of medroxyprogesterone on theophylline disposition. Journal of Clinical Pharmacology 23: 281–284, 1983
Grabowski N, May JJ, Pratt DS, Richtsmeier WJ, Bertino Jr JS, et al. The effect of split virus influenza vaccination on theophylline pharmacokinetics. American Review of Respiratory Disease 131: 934–938, 1985
Grambau GR, Conlon PF, Johnson CE, Weg JG. Predicted versus actual plasma theophylline concentrations at steady state and as influenced by furosemide. American Review of Respiratory Disease 117: A66, 1978
Gray JD, Renton KW, Hung OR. Depression of theophylline elimination following BCG vaccination. British Journal of Clinical Pharmacology 16: 735–737, 1983
Green AW, Ebling WF, Gardner MJ, Jusko WJ. Cimetidine-methrednisolone-theophylline metabolic interaction. American journal of Medicine 77: 1115–1118, 1984
Green JA, dementi WA. Decrease in theophylline clearance after administration of erythromycin to a patient with obstructive lung disease. Drug Intelligence and Clinical Pharmacy 17: 370–372, 1983
Greene J, Danish M, Ragni M, Leeks H, Yaffe S. The effect of phenobarbital upon theophylline elimination kinetics in asthmatic children. Annals of Allergy 39: 69, 1977
Gregoire SL, Grasela Jr TH, Freer JP, Tack KJ, Schentag JJ. Inhibition of theophylline clearance by coadministered ofloxacin without alteration of theophylline effects. Antimicrobial Agents and Chemotherapy 31: 375–378, 1987
Grygiel JJ, Miners JO, Drew R, Birkett DJ. Differential effects of Cimetidine on theophylline metabolic pathways. European Journal of Clinical Pharmacology 26: 335–340, 1984
Grygiel JJ, Wing LMH, Farkas J, Birkett OJ. Effects of allopu-rinol on theophylline metabolism and clearance. Clinical Pharmacology and Therapeutics 26: 660–667, 1979
Gugler R, Wolf M, Hansen H-H, Jensen JC. The inhibition of drug metabolism by Cimetidine in patients with liver cirrhosis. klinische Wochenschrift 62: 1126–1131, 1984
Gundert-Remy U, Hildebrandt R, Hengen N, Weber E. Non-linear elimination processes of theophylline. European Journal of Clinical Pharmacology 24: 71–78, 1983a
Gundert-Remy U, Hildebrandt R, Weber E. Cimetidine-theo-phylline interaction/impairment of renal clearance in addition to metabolic clearance. British Journal of Clinical Pharmacology 15: 608P, 1983b
Gutfeld MB, Welage LS, Walawander CA, Wilton JH, Harrison NJ. The influence of intravenous Cimetidine dosage regimens on the disposition of theophylline. Journal of Clinical Pharmacology 29: 665–669, 1989
Halawa B. Interakcje teofiliny z erytromycyna ryfampicyna i lin-komycyna. Polski Tygodnik Lekarski 43: 854–857, 1988
Hammond D, Abate MA. Theophylline toxicity, acute illness, and cefaclor administration. DICP — Annals of Pharmacotherapy 23: 339–340, 1989
Hannan SE, May JJ, Pratt DS, Richtsmeier WJ, Bertino Jr JS. Lack of effect of whole virus influenza vaccine on theophylline pharmacokinetics. American Review of Respiratory Disease 133: A6I, 1986
Harrod CS. Theophylline toxicity and nifedipine. Annals of Internal Medicine 106: 480, 1987
Hasegawa T, Takagi K, Kuzuya T, Nadai M, Apichartpichean R, Muraoka I. Effect of mequitazine on the pharmacokinetics of theophylline in asthmatic patients. European Journal of Clinical Pharmacology 38: 255–258, 1990
Hauser AR, Lee C, Teague RB, Mullins C. The effect of rifampin on theophylline disposition. Clinical Pharmacology and Therapeutics 33: 254, 1983
Hecht L, Murray WE Theophylline-pyrantel pamoate interaction. DICP- Annals of Pharmacotherapy 23: 258, 1989
Hemstreet MP, Miles MV. Rutland RO Effect of intravenous isoproterenol on theophylline kinetics. Journal of Allergy and Clinical Immunology 69: 360–364, 1982
Hendeles L, Weinberger M, Smith G, Milavetz G. The interaction of Cimetidine and theophviline. Drug Intelligence and Clinical Pharmacy 15: 808–809, 1981
Hendeles L, Wyatt R, Weinberger M, Schottelius D, Fincham R. Decreased oral Phenytoin absorption following concurrent theophylline administration. Journal of Allergy and Clinical Immunology 63: 156, 1979
Hildebrandt R, Gundert-Remy U, Moller H, Weber E. Lack of clinically important interaction between erythromycin and theophylline. European Journal of Clinical Pharmacology 26: 485–489, 1984
Hildebrandt R, Moller H, Gundert-Remy U. Influence of theophylline on the renal clearance of erythromycin. International Journal of Clinical Pharmacology, Therapy and Toxicology 25: 601–604, 1987
Ho G, Tierney MG, Dales RE. Evaluation of the effect of norfloxacin on the pharmacokinetics of theophylline. Clinical Pharmacology and Therapeutics 44: 35–38, 1988
Hoglund P, Nilsson LG, Paulsen O. Interaction between isoniazid and theophylline. European Journal of Respiratory Diseases 70: 110–116, 1987
Hsu K, Garton A, Sproule BJ, Tarn YK, Legatt D, et al. The influence of orally administered Cimetidine and theophylline on the elimination of each drug in patients with chronic airways obstruction. American Review of Respiratory Disease 130: 740–743, 1984
Huang S-M, Weintraub HS, Marriott TB, Marinan B, Abels R, et al. Etintidine-theophylline interaction study in humans. Bio-pharmaceutics and Drug Disposition 8: 561–569, 1987
Iliopoulou A, Aldhous ME, Johnston A, Turner P. Pharmacokinetic interaction between theophylline and erythromycin. British Journal of Clinical Pharmacology 14: 495–499, 1982
Jackson JE, Plachetka JR. More on cimetidine-theophylline interaction. Drug Intelligence and Clinical Pharmacy 15: 809–810, 1981
Jackson JE, Powell JR, Wandell M, Bentley J, Dorr R. Cimetidine-theophylline interaction. Pharmacologist 22: 231, 1980
Jackson JE, Powell JR, Wandell M, Bentley J, Dorr R. Cimetidine decreases theophylline clearance. American Review of Respiratory Disease 123: 615–617, 1981
Jackson SHD, Shah K, Debbas NMG, Johnston A, Peverel-Cooper CA, et al. The interaction between i.v. theophylline and chronic oral dosing with slow release nifedipine in volunteers. British Journal of Clinical Pharmacology 21: 389–392, 1986
Janicke U-A, Krudewagen B, Schulz A, Gundert-Remy U. Absence of a clinically significant interaction between theophylline and furosemide. European Journal of Clinical Pharmacology 33: 487–491, 1987
Jonkman JHG. Biopharmaceutical and pharmacokinetic drug interactions with theophylline: In Jonkman et al. (Eds) The use of sustained release theophylline in the treatment of chronic reversible airways obstruction, pp. 98–110. Excerpta Medica, Amsterdam, 1984
Jonkman JHG. Food interactions with sustained-release theophylline preparations: a review. Clinical Pharmacokinetics 16: 162–179, 1989
Jonkman JHG, Borgstrom L, van der Boon WJV, de Noord OE. Theophylline-terbulaline, a steady state study on possible pharmacokinetic interactions with special reference to chron-opharmacokinetic aspects. British Journal of Clinical Pharmacology 26: 285–293, 1988a
Jonkman JHG, Hendeles L. The theophylline-erythromycin interaction. Chest 84: 309–310, 1983
Jonkman JHG, Nicholson KG, Farrow PR, Eckert M, Grasmeijer G, et al. Effects of alpha-interferon on theophylline pharmacokinetics and metabolism. British Journal of Clinical Pharmacology 27: 795–802, 1989
Jonkman JHG, van der Boon WJ, Shoenmaker R, Holtkamp A, Hempenius J. No effect of cefaclor on theophylline pharmacokinetics. European Journal of Respiratory Diseases 66: 47–49, 1985a
Jonkman JHG, van der Boon WJV, Schoenmaker R, Holtkamp A, Hempenius J. Lack of effect of amoxicillin on theophylline pharmacokinetics. British Journal of Clinical Pharmacology 19: 99–101, 1985b
Jonkman JHG, van der Boon WJV, Schoenmaker R, Holtkamp A, Hempenius J. No influence of doxycycline on theophylline pharmacokinetics. Therapeutic Drug Monitoring 7: 92–94, 1985c
Jonkman JHG, van der Boon WJV, Schoenmaker R, Holtkamp AH, Hempenius J. Lack of influence of co-trimoxazole on theophylline pharmacokinetics. Journal of Pharmaceutical Sciences 74: 1103–1104, 1985d
Jonkman JHG, van der Boon WJV, Schoenmaker R, Holtkamp A, Hempenius J. Clinical pharmacokinetics of theophylline during co-treatment with cefaclor. International Journal of Clinical Pharmacology, Therapy and Toxicology 24: 88–92, 1986
Jonkman JHG, Wymenga ASC, de Zeeuw RA, van der Boon WVJ, Beugelink JK, et al. No effect of influenza vaccination on theophylline pharmacokinetics as studied by ultraviolet spectrophotometry, H PLC, and EMIT assay methods. Therapeutic Drug Monitoring 10: 345–348, 1988b
Jusko WJ, Gardner MJ, Mangione A, Schentak JJ, Koup JR, et al. Factors affecting theophylline clearances: age, tobacco, marijuana, cirrhosis, congestive heart failure, obesity, oral contraceptives, benzodiazepines, barbiturates and ethanol. Journal of Pharmaceutical Sciences 68: 1358–1366, 1979
Kadlec GL, Thanh Ha, L, Jarboe CH, Richards D, Karibo JM. Effect of ampicillin on theophylline half-life in infants and young children. Southern Medical Journal 71: 1548, 1978
Kandrotas RJ, Cranfield TL, Gal P, Ransom JL, Weaver RL. Effect of phenobarbital administration on theophylline clearance in premature neonates. Therapeutic Drug Monitoring 12: 139–143, 1990
Katz A, Buskila D, Sukenik S. Oral exiletine-theophylline interaction. International Journal of Cardiology 17: 227–228, 1987
Kawakatsu K, Kino T, Yasuba H, Kawaguchi H, Tsubata R, et al. Effect of ozagrel (OKY-046), a thromboxane synthetase inhibitor, on theophylline pharmacokinetics in asthmatic patients. International Journal of Clinical Pharmacology Therapy and Toxicology 28: 158–163, 1990
Kelly HW. Lack of evidence for reduction of theophylline clearance by ranitidine. American Journal of Medicine 86: 629–630, 1989
Kelly HW, Powell JR. Donohue JF, Ranitidine at very large doses does not inhibit theophylline elimination. Clinical Pharmacology and Therapeutics 39: 577–581, 1986
Kelly JF, Tang-Liu DD-S, Lazo S, Upton RA, Williams RL. The effect of Cimetidine on theophylline metabolism in the elderly. Clinical Pharmacology and Therapeutics 31: 238–239, 1982
Kelly SJ, Pingleton SK, Ryan PB, Melethil S. The lack of influence of erythromycin on plasma theophylline levels. Chest 78: 523–524, 1980
Kelly SJ, Pingleton SK, Ryan PB, Melethil S. No effect of erythromycin on plasma theophylline levels. Clinical Research 29: 796A, 1981
Kessler KM, Interian Jr A, Cox M, Topaz O, De Marchena EJ, et al. Proarrhythmia related to a kinetic and dynamic interaction of mexiletine and theophylline. American Heart Journal 117: 964–966, 1989
Koren G, Greenwald M. Decreased theophylline clearance causing toxicity in children during viral epidemics. Journal of Asthma 22: 75–79, 1985
Koup JR, Toothaker RD, Posvar E, Sedman AJ, Colburn. WA. Theophylline dosage adjustment during enoxacin coadministration. Antimicrobial Agents and Chemotherapy 34: 803–807, 1990
Kozak PP, Cummins LH, Cullman SA. Administration of erythromycin to patients on theophylline. Journal of Allergy and Clinical Immunology 60: 149–151, 1977
Kraemcr MJ, Furukawa CT, Koup JR, Shapiro GG, Pierson WE, et al. Altered theophylline clearance during an influenza B outbreak. Pediatrics 69: 476–480, 1982
Kraemer MJ, Furukawa CT, Shapiro GG, Bierman CW, Pierson WE. Altered theophylline clearance during an influenza B epidemic. Journal of Allergy and Clinical Immunology 67: 40, 1981
Krstenansky PM, Javaheri S, Thomas JP, Thomas RL. Effect of continuous Cimetidine infusion on steady-state theophylline concentration. Clinical Pharmacy 8: 206–209, 1989
Lacroix C, Nouveau J, Hubscher PH, Tardif D, Ray M, et al. Influence de l’idrocilamide sur le métabolisme de la théophylline. Revue de Pneumologie Clinique 42: 164–166, 1986
LaForce CF, Miller MF, Chai H. Effect of erythromycin on theophylline clearance in asthmatics. Journal of Allergy and Clinical Immunology 67: 40 (1981a)
LaForce CF, Miller MF, Chai H. Effect of erythromycin on theophylline clearance in asthmatic children. Journal of Pediatrics 99: 153–156, 1981b
LaForce CF, Miller MF, Kaliskar A. Effect of erythromycin base on theophylline pharmacokinetics in asthmatic children. Journal of Allergy and Clinical Immunology 71: 131, 1983
Lalonde RL, Koob RA, McLean WM, Balsys AJ. Influence of Cimetidine on theophylline pharmacokinetics at steady state. Clinical Pharmacology and Therapeutics 31: 241–242, 1982
Lalonde RL, Koob RA, McLean WM, Balsys AJ. The effects of Cimetidine on theophylline pharmacokinetics at steady state. Chest 83: 221–224, 1983
Landay RA, Gonzalez MA, Taylor JC. Effect of phenobarbital on theophylline disposition. Journal of Allergy and Clinical Immunology 62: 27–29, 1978
Lavarenne J, Paire M, Talon O. Influence d’un nouveau macrolide, la mid camycine, sur les taux sanguins de théophylline. Thérapie 36: 451–456, 1981
Leavengood DO, Bunker-Soler AL, Nelson HS. The effect of corticosteroids on theophylline metabolism. Annals of Allergy 50: 249–251, 1983
Lew G, Murray WE, Lane JR, Haeger E. Theophylline-thiabendazole drug interaction. Clinical Pharmacy 8: 225–227, 1989
Lo KF, Nation RL, Sansom LN. Lack of effect of co-trimoxazole on the pharmacokinetics of orally administered theophylline. Biopharmaceutics and Drug Disposition 10: 573–580, 1989
Lofgren RP, Gilbertson RA. Cimetidine and theophylline. Annals of Internal Medicine 96: 378, 1982
Loi CM, Day JD, Jue SG, Bush ED, Costello P, et al. Dose-dependent inhibition of theophylline metabolism by disulfiram in recovering alcoholics. Clinical Pharmacology and Therapeutics 45: 476–486, 1989
Lombardi TP, Bertino JS, Goldberg A, Middleton Jr E, Slaughter RL. The effects of a beta-2 selective adrenergic agonist and a beta-nonselective antagonist on theophylline clearance. Journal of Clinical Pharmacology 27: 523–529, 1987
Luskin SS, Fitzsimmons WE, MacLeod CM, Luskin AT. Pharmacokinetic evaluation of the terfenadine-theophylline interaction. Journal of Allergy and Clinical Immunology 83: 406–411, 1989, Erratum. Journal of Allergy and Clinical Immunology 83: 1082, 1989
MacLeod S, Koren G, Chin T, Correia J, Tesoro A. Theophylline pharmacokinetics in adolescent females following coadministration of oral contraceptives. Clinical Pharmacology and Therapeutics 37: 209, 1985
Maddux MS, Bauman JL. The theophylline-erythromycin interaction. Chest 84: 311–312, 1983
Maddux MS, Leeds NH, Organek HW, Hasegawa GR, Bauman JL. The effect of erythromycin on theophylline pharmacokinetics at steady state. Chest 81: 563–565, 1982
Maesen FPV, Teengs JP, Baur C, Davies BI. Quinolones and raised plasma concentrations of theophylline. Lancet 2: 530, 1984
Manfredi RL, Vesell ES. Inhibition of theophylline metabolism bv long-term allopunnol administration. Clinical Pharmacology and Therapeutics 29: 224–229, 1981
Maponga C, Barlow JC, Schentag JJ. Lack of effect of Piroxicam on theophylline clearance in healthy volunteers. DICP — Annals of Pharmacotherapy 24: 123–126, 1990
Marquis J-F, Carruthers SG, Spence JD, Brownstone YS, Too-good JH. Phenvtoin-theophvlline interaction. New England Journal of Medicine 307: 1189–1190, 1982
Mathis JW, Prince RA, Weinberger MM, McElnay JC. Effect of tetracvcline hydrochloride on theophylline kinetics. Clinical Pharmacy 1: 446–448, 1982
May DC, Jarboe CH, Ellenburg DT, Roe EJ, Karibo J. The effects of erythromycin on theophylline elimination in normal males. Journal of Clinical Pharmacology 22: 125–130, 1982
McEwen J, McMurdo MET, Moreland TA. The effects of once-daily dosing with ranitidine and Cimetidine on theophylline pharmacokinetics. European Journal of Drug Metabolism and Pharmacokinetics 13: 201–205, 1988
Melethil S, Dutta A, Ryan PB, Pingleton S, Kelly SJ. Steady state urinary excretion of theophylline and its metabolites in the presence of erythromycin. Research Communications in Chemical Pathology and Pharmacology 35: 341–344, 1982
Meredith CG, Christian CD, Johnson RF, Troxell R, Davis GL, et al. Effects of influenza virus vaccine on hepatic drug metabolism. Clinical Pharmacology and Therapeutics 37: 396–401, 1985
Miller M, Cosgriff J, Kwong T, Morken DA. Influence of Phenytoin on theophylline clearance. Clinical Pharmacology and Therapeutics 35: 666–669, 1984
Miller ME, Cosgriff JM, Morken D, Kwong T. The effect of dilantin on theophylline elimination. Clinical Research 31: 104A, 1983
Miners JO, Grygiel JJ, Drew R, Birken DJ. Interaction between Cimetidine and theophylline in smokers and nonsmokers. Clinical and Experimental Pharmacology and Physiology 8: 633–634, 1981
Miners JO, Wing LMH, Lillywhite KJ, Robson RA. Selectivity and dose-dependence of the inhibitory effect of propranolol on theophylline metabolism in man. British Journal of Clinical Pharmacology 20: 219–223, 1985
Monks TJ, Caldwell J, Smith R. Influence of methytxanthine-contaimng foods on theophylline metabolism and kinetics. Clinical Pharmacology and Therapeutics 26: 513–524, 1979
Monks TJ, Lawrie CA, Caldwell J. The effect of increased caffeine intake on the metabolism and pharmacokinetics of theophylline in man. Biopharmaceutics and Drug Disposition 2: 31–37, 1981
Mulkey PM, Murphy JE, Schleifer NH. Steady-state theophylline pharmacokinetics during and after short-term Cimetidine administration. Clinical Pharmacy 2: 439–441, 1983
Murray MD, Brown BK. Theophylline-erythromycin interaction in an infant. Clinical Pharmacy 1: 107–111, 1982
Myhre KJ, Walstad RA. The influence of antacid on the absorption of two different sustained-release formulations of theophylline. British Journal of Clinical Pharmacology 15: 683–687, 1983
Myhre KI, Walstad RA. Antacids and slow-release theophylline: In Jonkman et al. (Eds) The use of sustained release theophylline in the treatment of chronic reversible airways obstruction, pp. 157–163, Excerpta Medica, Amsterdam, 1984
Nafziger AN, May JJ, Bertino Jr JS. Inhibition of theophylline elimination by diltiazem therapy. Journal of Clinical Pharmacology 27: 862–865, 1987
Nakagawa RS. Theophylline-furosemide interaction? American Journal of Hospital Pharmacy 39: 242, 1982
Nielsen-Kudsk JE, Buhl JS. Johannessen AC, Verapamil-induced inhibition of theophylline elimination in healthy humans. Pharmacology and Toxicology 66: 101–103, 1990
Niki Y, Soejima R, Kawane H, Sumi M, Umeki S. New synthetic quinolone antibacterial agents and serum concentration of theophylline. Chest 92: 663–669, 1987
Niki Y, Umeki S, Kawane H, Soejimai R. The newest quinolone antibacterial agents and theophylline. Chest 95: 486, 1989
Nix DE, DeVito JM, Whitbread MA, Schentak JJ. Effect of multiple dose oral ciprofloxacin on the pharmacokinetics of theophylline and indocyanine green. Journal of Clinical Pharmacology 26: 545, 1986
Nix DE, DeVito JM, Whitbread MA, Schentag JJ. Effect of multiple dose oral ciprofloxacin on the pharmacokinetics of theophylline and indocyanine green. Journal of Antimicrobial Chemotherapy 19: 263–269, 1987
Nix DE, Norman A, Schentag JJ. Effect of lomefloxacin on theophylline pharmacokinetics. Antimicrobial Agents and Chemotherapy 33: 1006–1008, 1989
O’Rourke PP, Crone RK. Effect of isoproterenol on measured theophylline levels. Critical Care Medicine 12: 373–375, 1984
Paladino JA, Blumer NA, Maddux RR. Effect of secobarbital on theophylline clearance. Therapeutic Drug Monitoring 5: 135–139, 1983
Parish RA, Haulman NJ, Burns RM. Interaction of theophylline with erythromycin base in a patient with seizure activity. Pediatrics 72: 828–830, 1983
Parrillo SJ, Venditto M. Elevated theophylline blood levels from institution of nifedipine therapy. Annals of Emergency Medicine 13: 216–217, 1984
Pasic J, Jackson SHD, Johnston A, Peverel-Cooper CA, Turner P, et al. The interaction between chronic oral slow-release theophylline and single-dose intravenous erythromycin. Xe-nobiotica 17: 493–497, 1987
Patriarca PA, Kendal AP, Stricof RL, Weber JA, Meissner MK, et al. Influenza vaccination and warfarin or theophylline toxicity in nursing-home residents. New England Journal of Medicine 308: 1601–1602, 1983
Paulsen O, Hoglund P, Nilsson L-G, Bengtsson H-I. The interaction of erythromycin with theophylline. European Journal of Clinical Pharmacology 32: 493–498, 1987
Perault MC, Griesemann E, Bouquet S, Lavoisy J, Vandel B. A study of the interaction of viloxazine with theophylline. Therapeutic Drug Monitoring II: 520–522, 1989
Pfeifer HJ, Greenblalt DJ, Friedman P. Effect of antibiotics on theophylline kinetics in humans. Clinical Pharmacology and Therapeutics 23: 124–125, 1978
Pfeifer HJ, Greenblalt DJ, Friedman P. Effects of three antibiotics on theophylline kinetics. Clinical Pharmacology and Therapeutics 26: 36–40, 1979
Piafsky KM, Sitar DS, Ogilvie RI. Effect of phenobarbital administration on theophylline kinetics. Clinical Research 23: 6I0A, 1975
Piafsky KM, Sitar DS, Ogilvie RI. Effect of phenobarbital on the disposition of intravenous theophylline. Clinical Pharmacology and Therapeutics 22: 336–339, 1977
Pingleton SK, Kelly SJ, Ryan PB. Lack of effect of erythromycin on theophylline serum levels 78. Chest 78: 352, 1980
Powell JR, Rogers JF, Wargin WA, Cross RE, Eshelman FN. The influence of Cimetidine vs ranitidine on theophylline pharmacokinetics. Clinical Pharmacology and Therapeutics 31: 261, 1982
Powell JR, Rogers JF, Wargin WA, Cross RE, Eshelman FN. Inhibition of theophylline clearance by Cimetidine but not ranitidine. Archives of Internal Medicine 144: 484–486, 1984
Powell JR, Thiercelin J, Vozeh S, Sanson L, Riegelman S. The influence of cigarette smoking and sex on theophylline disposition. American Review of Respiratory Disease 116: 17–23, 1977
Powell JR, Vozeh S, Hopewell P, Costello J, Sheiner LB, et al. Theophylline disposition in acutely ill hospitalized patients. American Review of Respiratory Disease 118: 229–238, 1978
Powell-Jackson PR, Jamieson AP, Gray B, Moxham J, Williams R. Effect of rifampicin administration on theophylline pharmacokinetics in man. Thorax 39: 692, 1984
Powell-Jackson PR, Jamieson AP, Gray BJ, Moxham J, Williams R. Effect of rifampicin administration on theophylline pharmacokinetics in humans. American Review of Respiratory Disease 131: 939–940, 1985
Prince RA, Wing DS, Hendeles LS, Weinberger MM. The effect of erythromycin on theophylline kinetics. Drug Intelligence and Clinical Pharmacy 14: 637, 1980
Prince RA, Wing DS, Weinberger MM, Hendeles LS, Riegelman S. Effect of erythromycin on theophylline kinetics. Journal of Allergy and Clinical Immunology 68: 427–431, 1981
Principi N, Onorato J, Giuliani MG, Vigano A. Effect of miocamycin on theophylline kinetics in children. European Journal of Clinical Pharmacology 31: 701–704, 1987
Raoof S, Wollschlager C, Khan F. Serum theophylline levels are increased by ciprofloxacin (Bay 9867). a new quinolone antibiotic. Chest 88: 32S, 1985
Raoof S, Wollschlager C, Khan FA. Ciprofloxacin increases serum levels of theophylline. American Journal of Medicine 82 (Suppl. 4A): 115–118, 1987
Reed RC. Antacid influence on theophylline bioavailability. Drug Intelligence and Clinical Pharmacy 16: 479–480, 1982
Reed RC, Schwartz HJ. Phenytoin-theophylline-quinidine interaction. New England Journal of Medicine 308: 724–725, 1983
Reed RC, Schwartz HJ. Lack of influence of an intensive antacid regimen on theophylline bioavailability. Journal of Pharmacokinetics and Biopharmaceutics 12: 315–331, 1984
Reisz G, Pingleton SK, Melethil S, Ryan P. The effect of erythromycin on theophylline pharmacokinetics in chronic bronchitis. American Review of Respiratory Disease 127: 581–584, 1983
Reisz GR, Pingleton SK, Ryan PB, Melethil SK. Alteration of theophylline kinetics by erythromycin in chronic bronchitis. Clinical Research 29: 740A, 1981
Reisz GR, Ryan PB, Melethil S, Pingleton SK. Erythromycin induced changes in theophylline kinetics in chronic bronchitis. American Review of Respiratory Disease 125: A95, 1982
Reitberg DP, Bernhard H, Schcntag JJ. Alteration of theophylline clearance and half-life by Cimetidine in normal volunteers. Annals of Internal Medicine 92: 582–585, 1981
Reitberg DP, Klarnet JP, Carlson JK, Schentag JJ. Effect of metronidazole on theophylline pharmacokinetics. Clinical Pharmacy 2: 441–444, 1983
Renton KW. Theophylline pharmacokinetics in respiratory viral illness. Lancet 2: 160–161, 1978
Renton KW. Effects of infection and immune stimulation on theophylline metabolism. Seminars in Perinatology 5: 378–382, 1981
Renton KW, Gray JD. Decreased elimination of theophylline after influenza vaccination. Canadian Medical Association Journal 126: 470, 1982
Renton KW, Gray JD, Hall RI. Decreased elimination of theophylline after influenza vaccination. Canadian Medical Association Journal 123: 288–290, 1980
Renton KW, Gray JD, Hung OR. Depression of theophylline elimination by erythromycin. Clinical Pharmacology and Therapeutics 30: 422–426, 1981
Richer C, Mathieu M, Bah H, Thuillez C, Duroux P, et al. Theophylline kinetics and ventilatory flow in bronchial asthma and chronic airflow obstruction: influence of erythromycin. Clinical Pharmacology and Therapeutics 31: 579–586, 1982
Roberts RK, Grice J, McGuffie C. Cimetidine-theophylline interaction in patients with chronic obstructive airways disease. Medical Journal of Australia 140: 279–280, 1984
Roberts RK, Grice J, McGuffie C, Heilbronn L. Oral contraceptive steroids impair the elimination of theophylline. Journal of Laboratory and Clinical Medicine 101: 821–825, 1983
Roberts RK, Grice J, Wood J, Petroff V, McGuffie C. Cimetidine impairs the elimination of theophylline and antipyrine. Gastroenterology 81: 19–21, 1981
Robson RA, Miners JO, Birkett DJ. Selective inhibitory effects of nifedipine and verapamil on oxidative metabolism: effects on theophylline. British Journal of Clinical Pharmacology 25: 397–400, 1988
Robson RA, Miners JO, Whitehead AG, Birkett DJ. Specificity of the inhibitory effect of dextropropoxyphene on oxidative drug metabolism in man: effects on theophylline and tolbutamide disposition. British Journal of Clinical Pharmacology 23: 772–775, 1987
Robson RA, Miners JO, Wing LMH, Birkett DJ. Theophyllinerifampicin interaction: non-selective induction of theophylline metabolic pathways. British Journal of Clinical Pharmacology 18: 445–448, 1984
Rogge MC, Solomon WR, Sedman AJ, Welling PG, Koup JR, et al. The Iheophylline-enoxacin interaction: II: Changes in the disposition of theophylline and its metabolites during intermittent administration of enoxacin. Clinical Pharmacology and Therapeutics 46: 420–428, 1989
Rogge MC, Solomon WR, Sedman AJ, Welling PG, Toothaker RD, et al. The theophyïline-enoxacm interaction: I. Effect of enoxacin dose size on theophylline disposition. Clinical Pharmacology and Therapeutics 44: 579–587, 1988
Rolf Smith S, Haffner CA, Kendall MJ. The influence of nifedipine and diltiazem on serum theophylline concentration-time profiles. Journal of Clinical Pharmacy and Therapeutics 14: 403–408, 1989
Rosenberry KR, Defusco CJ, Mansmann HC, McGeady SJ. Reduced theophylline half-life induced by carbamazepine therapy. Journal of Pediatrics 102: 472–474, 1983
Roy AK. Lack of evidence for reduction of theophylline clearance by ranitidine; the reply. American Journal of Medicine 86: 630–632, 1989
Roy AK, Cuda MP, Levine RA. Induction of theophylline toxicity and inhibition of clearance rates by ranitidine. American Journal of Medicine 85: 525–527, 1988
Ruff F. Interférences médicamenteuses de la theophylline: absence d’interaction théophylline-ranitidine. Nouvelle Presse Médicale II: 3512, 1982
Ruff F, Prosper M, Pujel JC. Theophylline et antibiotiques. Thérapie 39: 1–6, 1984
Ruff F, Saniais MC, Chastagnol D, Huchon G, Durieux P. Ma-crolide et theophylline: absence d’interaction josamycine-théo-phylline. Nouvelle Presse Médicale 10: 175, 1981
Rybak MJ, Bowles SK, Chandrasekar PH, Edwards DJ. Increased theophylline concentrations secondary to ciprofloxacin. Drug Intelligence and Clinical Pharmacy 21: 879–881, 1987
Saint-Salvi B, Tremblay D, Surjus A, Lefebvre MA. A study of the interaction of roxithromycin with theophylline and carbamazepine. Journal of Antimicrobial Chemotherapy 20 (Suppl. B): 121–129, 1987
Samigun, Mulyono, Santoso B. Lowering of theophylline clearance by isoniazid in slow and rapid acetylators. British Journal of Clinical Pharmacology 29: 570–573, 1990
San Joaquin VH, Reyes S, Marks MI. Influenza vaccination in asthmatic children on maintenance theophylline therapy. Clinical Pediatrics 21: 724–726, 1982
Sano M, Kawakatsu K, Ohkita C, Yamamoto I, Takeyama M, et al. Effects of enoxacin, ofloxacin and norfloxacin on theophylline disposition in humans. European Journal of Clinical Pharmacology 35: 161–165, 1988
Sano M, Yamamoto I, Ueda J, Yoshikawa E, Yamashina H, et al. Comparative pharmacokinetics of theophylline following two fluoroquinolones co-administration. European Journal of Clinical Pharmacology 32: 431–432, 1987
Sarkar M, Polk RE, Guzelian PS, Hunt C. Karnes HT In vitro effect of fluoroquinolones on theophylline metabolism in human liver microsomes. Antimicrobial Agents and Chemotherapy 34: 594–599, 1990
Schneider D, Gannon R, Sweeney K, Shore E. Theophylline and antiparasitic drug interactions. Chest 97: 84–87, 1990
Schwartz JI, Bachmann KA, Bond LW, Mahajan VK. Impact of Cimetidine on the pharmacokinetics of theophylline. Clinical Pharmacy 1: 534–538, 1982
Schwartz J, Jauregui L, Lettieri J, Bachmann K. Impact of ciprofloxacin on theophylline clearance and steady-state concentrations in scrum Antimicrobial Agents and Chemotherapy 32: 75–77, 1988
Seggen JS, Barzilay M, Schey G. No evidence for interaction between ranitidine and theophylline. Archives of Internal Medicine 147: 179–180, 1987
Seggev JS, Shefi M, Schey G, Farfel Z. Doxycycline does not affect theophylline levels. Annals of Allergy 54: 367, 1985
Sertl K, Rameis H, Meryn S. Pirenzepin es not alter the pharmacokinetics of theophylline. International Journal of Clinical Pharmacology. Therapy and Toxicology 25: 15–17, 1987
Shahccn O, Sliman NA, Al-Turk WA. Effect of Cimetidine on the pharmacokinetics of theophylline. General Pharmacology 19: 431–434, 1988
Shargel L, Stevens JS, Fuchs JE, Yu NBC. Effect of antacids on bioavailability of theophylline from rapid and timed-release drug products. Journal of Pharmaceutical Sciences 70: 599–602, 1981
Siddoway LA, Schwartz SL, Barbey JT, Woosley RL. Clinical pharmacokinetics of moricizine. American Journal of Cardiology 65: 21D–25D, 1990
Sirmans SM, Pieper JA, Lalonde RL, Smith DG, Self TH. Effect of calcium channel blockers on theophylline disposition. Clinical Pharmacology and Therapeutics 44: 29–34, 1988
Skinner MH, Lenert L, Blaschke TF. Theophylline toxicity subsequent to ranitidine administration: a possible drug-drug interaction. American Journal of Medicine 86: 129–132, 1989
Sklar SJ, Wagner JC. Enhanced theophylline clearance secondary to Phenytoin therapy. Drug Intelligence and Clinical Pharmacy 19: 34–36, 1985
Smith SR, Wiggins J, Stableforth DE, Skinner C, Kendall MJ. Effect of nifedipine on serum theophylline concentrations and asthma control. Thorax 42: 794–796, 1987
Snidow J, Stephens M, Self T, Stewart C, Bobo L, et al. Acute effects of short-term subcutaneous terbutaline on theophylline disposition. European Journal of Clinical Pharmacology 32: 191–193, 1987
Staib AH, Harder S, Fuhr U, Wack C. Interaction of quinolones with the theophylline metabolism in man: investigations with lomefloxacin and pipemidic acid. International Journal of Clinical Pharmacology Therapy and Toxicology 27: 289–293, 1989
Steeves RA, Robinson JD, McKenzie MW, Justus PG. Effects of metoclopramide on the pharmacokinetics of a slow-release theophylline product. Clinical Pharmacy 1: 356–360, 1982
Stratton MA. Theophylline-erythromycin base interaction: case report and kinetic profile. Clinical Pharmacy 2: 183–186, 1983
Straughn AB, Henderson RP, Lieberman PL, Self TH. Effect of rifampin on theophylline disposition. Therapeutic Drug Monitoring 6: 153–156, 1984
Stults BM, Hashisaki PA. Influenza vaccinations and theophylline pharmacokinetics in patients with chronic obstructive lung disease. Western Journal of Medicine 139: 651–654, 1983
Stults BM, Johnson JF, Higbee MD, Hardigan K. Effect of erythromycin stearate on serum theophylline concentrations in patients with chronic obstructive lung disease. Southern Medical Journal 76: 714–718, 1983
Stults BM, Johnson JF, Higbee MD, Hardigan K, Morgan R. The effect of oral erythromycin on serum levels of theophylline in patients with chronic obstructive pulmonary disease. American Review of Respiratory Disease 123: 105, 1981
Sugar AM, Kearns Jr PJ, Haulk AA, Rushing JL. Possible thiabendazole-induced theophylline toxicity. American Review of Respiratory Disease 122: 501–503, 1980
Sutton PL, Koup JR, Rose JQ, Middleton E. The pharmacokinetics of theophylline in pregnancy. Journal of Allergy and Clinical Immunology 61: 174, 1978
Sutton PL, Rose JQ, Goldstein S, Koup JR, Middleton E, et al. Theophylline pharmacokinetics during pregnancy and post partum. Journal of Allergy and Clinical Immunology 65: 177, 1980
Takagi K, Hasegawa T, Ogura Y, Suzuki R, Yamaki K, et al. Comparative studies on interaction between theophylline and quinolones. Journal of Asthma 25: 63–71, 1988a
Takagi K, Hasegawa T, Yamaki K, Suzuki R, Watanabe T, et al. Interaction between theophylline and enoxacin. International Journal of Clinical Pharmacology Therapy and Toxicology 26: 288–292, 1988b
Takagi K, Kuzuya T, Honuchi T, Nadai M, Apichartpichean R, et al. Lack of effect of repirinast on the pharmacokinetics of theophylline in asthmatic patients. European Journal of Clinical Pharmacology 37: 301–303, 1989
Tang-Liu DD-S, Williams RL, Riegelman S. Non-linear theophylline elimination. Clinical Pharmacology and Therapeutics 31: 358–369, 1982
Tarrus E, Cami J, Roberts DJ, Spickett RGW, Celdran E, et al. Accumulation of caffeine in healthy volunteers treated with furafylline. British Journal of Clinical Pharmacology 23: 9–18, 1987
Thompson JR, Burckart GJ, Self TH, Brown RE, Straughn AB. Isoniazid-induced alterations in theophylline pharmacokinetics. Current Therapeutic Research 32: 921–925, 1982
Thomson AH, Thomson GD, Hepburn M, Whiting B. A clinically significant interaction between ciprofloxacin and theophylline. European Journal of Clinical Pharmacology 33: 435–436, 1987
Toback JW, Gilman ME. Theophylline-furosemide inactivation? Pediatrics 71: 140–141, 1983
Tornatore KM, Kanarkowski R, McCarthy TL, Gardner MJ, Yurchak AM, et al. Effect of chronic oral contraceptive steroids on theophylline disposition. European Journal of Clinical Pharmacology 23: 129–134, 1982
Torrent J, Izquierdo I, Cabezas R, Jane F. Theophylline-isoniazid interaction. DICP — Annals of Pharmacotherapy 23: 143–145, 1989
Ueno K, Miyai K, Seki T, Kawaguchi Y. Interaction between theophylline and mexiletine. DICP — Annals of Pharmacotherapy 24: 471–472, 1990
Upton RA, Thiercelin J-F, Guentert TW, Wallance SM, Powell JR, et al. Intra-individual variability in theophylline pharmacokinetics: statistical verification in 39 of 60 healthy young adults. Journal of Pharmacokinetics and Biopharmaceutics 10: 123–134, 1982a
Upton RA, Thiercelin J-F, Moore JK, Riegelman S. A method for estimating within-individual variability in clearance and in volume of distribution from standard bioavailability studies. Journal of Pharmacokinetics and Biopharmaceutics 10: 135–146, 1982b
Uzzan D, Uzzan B, Bernard N, Caubarrere I. Interaction médicamenteuse de la Cimetidine et de la theophylline. Nouvelle Presse Médicale II: 1950, 1982
Vestal RE, Cusack BJ, Mercer GD, Dawson GW, Park BK. Aging and drug interactions: I. Effect of Cimetidine and smoking on the oxidation of theophylline and Cortisol in healthy men. Journal of Pharmacology and Experimental Therapeutics 241: 488–500, 1987
Vestal RE, Thummel KE, Musser B, Jue SG. Stable isotope methodology in a pharmacokinetic study of the interaction of theophylline and Cimetidine. Biomedical Mass Spectrometry 9: 340–346, 1982a
Vestal RE, Thummel KE, Musser B, Mercer GD. Cimetidine inhibits theophylline clearance in chronic obstructive pulmonary disease: a study using stable isotope methodology. Clinical Research 30: 27A, 1982b
Vestal RE, Thummel KE, Musser B, Mercer GD. Cimetidine inhibits the theophylline clearance in patients with chronic obstructive pulmonary disease: a study using stable isotope methodology during multiple oral dose administration. British Journal of Clinical Pharmacology 15: 411–418, 1983
Vozeh S, Powell JR, Cupit GC, Riegelman S, Sheiner LB. Influence of allopunnol on theophylline disposition in adults. Clinical Pharmacology and Therapeutics 27: 194–197, 1980
Walker SB, Middelkamp JN. Theophylline toxicity and viral infections. Pediatrics 70: 508, 1982
Walker S, Schrieber L, Middelkamp JN. Serum theophylline levels after influenza vaccination. Canadian Medical Association Journal 125: 243–244, 1981
Weber WW, Hein DW. Clinical pharmacokinetics of isoniazid. Clinical Pharmacokinetics 4: 401–422, 1979
Weinberger M. The theophylline-erythromycin interaction. Chest 84: 310–311, 1983
Weinberger M, Bronsky E. Interaction of ephedrine and theophylline. Clinical Pharmacology and Therapeutics 15: 223, 1974
Weinberger M, Bronsky E, Bensch GW, Bock GN, Yecies JJ. Interaction of ephedrine and theophylline. Clinical Pharmacology and Therapeutics 17: 585–592, 1975
Weinberger M, Hudgel D, Spector S, Chidsey C. Troleandomycin (TAO): an inhibitor of theophylline metabolism. Journal of Allergy and Clinical Immunology 57: 262, 1976
Weinberger M, Hugdel D, Spector S, Chidsey C. Inhibition of theophylline clearance by troleandomycin. Journal of Allergy and Clinical Immunology 59: 228–231, 1977
Weinberger MM, Smith G, Milavetz G, Hendeles L. Decreased theophylline clearance due to Cimetidine. New England Journal of Medicine 304: 672, 1981
Wijnands WJA, van Herwaarden CLA, Vree TB. Enoxacin raises plasma theophylline concentrations. Lancet 2: 108–109, 1984
Wijnands WJA, Vree TB, Baars AM, van Herwaarden CLA. Steady-state kinetics of the quinolone derivatives ofloxacin, enoxacin, ciprofloxacin and Pefloxacin during maintenance treatment with theophylline. Drugs 34(Suppl. I): 159–169, 1987
Wijnands WJA, Vree TB, van Herwaarden CLA. Enoxacin decreases the clearance of theophylline in man. British Journal of Clinical Pharmacology 20 583–588, 1985
Wijnands WJA, Vree TB, van Herwaarden CLA. The effect of the 4-quinolone enoxacin on plasma theophylline concentrations. Pharmaceutisch Weekblad 8: 42–45, 1986a
Wijnands WJA, Vree TB, van Herwaarden CLA. The influence of quinolone derivatives on theophylline clearance. British Journal of Clinical Pharmacology 22: 677–683, 1986b
Williams SJ, Baird-Lambert J, Cantrill EM, Farrell GC. Interferon inhibits hepatic clearance of theophylline by a non competitive mechanism. Australian and New Zealand Journal of Medicine 17: 128, 1987a
Williams SJ, Baird-Lambert JA, Farrell GC. Inhibition of theophylline metabolism by interferon. Lancet 2: 939–941, 1987b
Winstanley PA, Tija J, Back DJ, Hobson D, Breckenridge AM. Lack of effect of highly purified subunit influenza vaccination on theophylline metabolism. British Journal of Clinical Pharmacology 20: 47–53, 1985
Wittenbrink-Dix AM, Neugebauer G, Fuhr U, Neubert P, Besenfelder E, et al. Study of potential kinetic interactions of picu-mast dihydrochloride and theophylline in vitro and after oral administration in man. Arzneimittel-Forschung 39: 1339–1343, 1989
Wood L, Grice J, Petroff V, McGuffie C, Roberts RK. Effect of Cimetidine on the disposition of theophylline. Australian and New Zealand Medical Journal 10: 586, 1980
Yoshimura N, Takeuchi H, Ogata H, Ishioka T, Aoi R. Effects of roxatidine acetate hydrochloride and Cimetidine on the pharmacokinetics of theophylline in healthy subjects. International Journal of Clinical Pharmacology Therapy and Toxicology 27: 308–312, 1989
Zarowitz BJM, Szefler SJ, Lasezkay GM. Effect of erythromycin base on theophylline elimination. Journal of Allergy and Clinical Immunology 67: 40, 1981a
Zarowitz BJM, Szefler SJ, Lasezkay GM. Effect of erythromycin base on theophylline kinetics. Clinical Pharmacology and Therapeutics 29: 601–605, 1981b
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Upton, R.A. Pharmacokinetic Interactions Between Theophylline and Other Medication (Part II). Clin Pharmacokinet 20, 135–150 (1991). https://doi.org/10.2165/00003088-199120020-00005
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003088-199120020-00005